ERBB2 c.2002G>C ;(p.G668R)

Variant ID: 17-37879627-G-C

NM_004448.2(ERBB2):c.2002G>C;(p.G668R)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Unique Genomic Alterations of Cerebrospinal Fluid Cell-Free DNA Are Critical for Targeted Therapy of Non-Small Cell Lung Cancer With Leptomeningeal Metastasis.

Frontiers In Oncology
Wang, Yongsheng Y; Jiang, Feng F; Xia, Ruixue R; Li, Ming M; Yao, Chengyun C; Li, Yan Y; Li, Hui H; Zhao, Qi Q; Shi, Mingke M; Yu, Yanzhe Y; Shao, Yang W YW; Zhou, Guoren G; Xia, Hongping H; Miao, Liyun L; Cai, Hourong H
Publication Date: 2021

Variant appearance in text: ERBB2: G668R
PubMed Link: 34671549
Variant Present in the following documents:
  • Main text
  • fonc-11-701171.pdf
View BVdb publication page



Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.

Plos One
Prentice, Leah M LM; Miller, Ruth R RR; Knaggs, Jeff J; Mazloomian, Alborz A; Aguirre Hernandez, Rosalia R; Franchini, Patrick P; Parsa, Kourosh K; Tessier-Cloutier, Basile B; Lapuk, Anna A; Huntsman, David D; Schaeffer, David F DF; Sheffield, Brandon S BS
Publication Date: 2018

Variant appearance in text: ERBB2: G668R
PubMed Link: 29698444
Variant Present in the following documents:
  • pone.0196434.s001.xlsx, sheet 3
  • pone.0196434.s001.xlsx, sheet 2
View BVdb publication page